Literature DB >> 6509309

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease.

R D Rafal, M I Posner, J A Walker, F J Friedrich.   

Abstract

Central to the concept of subcortical dementia is the implication that the increased response latencies, which distinguish the syndrome, are due to a slowing of thought processes. The term 'bradyphrenia' has been applied to this presumed slowing of thought in Parkinson's disease and implies (1) that increased response latencies are not strictly motoric but are due to slowed information processing, and (2) that the mental slowing is analogous to the bradykinesia observed in the motor domain and, hence, attributable to dysfunction of dopaminergic basal ganglia mechanisms. The current study attempts to validate this definition of bradyphrenia by seeking a slowing of thought in Parkinson's disease which can be linked directly to bradykinesia. Six parkinsonian patients with end-of-dose akinesia were studied in three experiments which allowed separation of the speed of specific cognitive operations from the speed of motor responses. Serving as their own controls, they were tested both during the parkinsonian 'off' state, and when bradykinesia was alleviated by drug therapy. Four additional patients with newly diagnosed Parkinson's disease were studied before and following successful treatment with L-DOPA/carbidopa. The first experiment measured the rate of memory scanning, the second examined orientating of attention in the visual fields, and the third measured the time required to prepare a manual movement. The results show that overall reaction time increased when patients were in the untreated state, but without a concomitant slowing of purely cognitive components. The slowing of thought often reported in Parkinson's disease does not necessarily accompany bradykinesia and thus may not be related to dopaminergic dysfunction. These findings emphasize the need for caution in inferring a slowing of thought from increased response latencies in subcortical disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6509309     DOI: 10.1093/brain/107.4.1083

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  32 in total

1.  The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Authors:  M Jahanshahi; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Cognitive components of reaction time in Parkinson's disease.

Authors:  N Jordan; H J Sagar; J A Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

3.  Relations between on-off phenomena and cognitive functions in Parkinson disease.

Authors:  G Meco; V Bonifati; L Bedini; A Bellatreccia; N Vanacore; A Franzese
Journal:  Ital J Neurol Sci       Date:  1991-02

Review 4.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

Review 5.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

6.  Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention.

Authors:  S Yamaguchi; S Kobayashi
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

7.  Flanker compatibility effects in patients with Parkinson's disease: impact of target onset delay and trial-by-trial stimulus variation.

Authors:  Xavier E Cagigas; J Vincent Filoteo; John L Stricker; Laurie M Rilling; Frances J Friedrich
Journal:  Brain Cogn       Date:  2006-10-17       Impact factor: 2.310

8.  Tolerance to the effects of ethanol on the speed and success of reaction time responding in the rat: effects of age and intoxicated practice.

Authors:  R D Mayfield; M Grant; T Schallert; W W Spirduso
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

Authors:  B Pillon; B Dubois; G Cusimano; A M Bonnet; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

10.  Programming and execution of sequential movements in Parkinson's disease.

Authors:  R D Rafal; A W Inhoff; J H Friedman; E Bernstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.